{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:40:23Z","timestamp":1782286823346,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008436","name":"Ernst und Berta Grimmke Stiftung","doi-asserted-by":"publisher","award":["14\/22"],"award-info":[{"award-number":["14\/22"]}],"id":[{"id":"10.13039\/501100008436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008662","name":"Joachim Herz Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Proliferative vitreoretinopathy (PVR) is a complication of retinal detachment which requires multiple vitreoretinal surgical interventions and frequent use of oil endotamponade. In this study, we conducted an in-depth analysis of complications associated with the use of heavy silicone oil in the management of inferior PVR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective cohort study of 20 eyes that underwent vitrectomy for inferior PVR with use of heavy silicone oil (Densiron 68) between March 2021 and October 2022 at Oxford Eye Hospital. Complications were classified into major categories relating to intraocular pressure, inflammation, lens, and oil emulsification\/migration. Visual outcomes and surgical success rate were also evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Fill-induced pressure spikes (&gt;\u200930 mmHg) within 14 days post-surgery were common after Densiron tamponade, especially in patients previously on glaucoma drops. The number of glaucoma drugs were increased in 45% of patients during Densiron tamponade. In 20% of cases, an increased medication was continued long-term after Densiron removal. Significant cataract progression occurred in all phakic patients. In 25% of pseudophakic cases, posterior capsule opacification was noted. Inflammatory complications, such as anterior uveitis, were rare and any cystoid macular oedema was transient. No unexplained acute loss of vision following Densiron removal was encountered. The anatomical success rate at 30 days after Densiron removal was 70%. The mean (\u00b1\u2009SD) best-corrected visual acuities were 1.04 (\u00b1\u20090.79), 0.85 (\u00b1\u20090.62) and 0.50 (\u00b1\u20090.51) logMAR prior, during and after Densiron tamponade, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The outcomes in this cohort treated with Densiron 68 were comparable to previously reported anatomical and functional results in cases with inferior PVR. IOP and lens-related complications require additional treatment during or after Densiron tamponade. Inflammatory complications rarely occurred over tamponade durations of around three months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Analyses were conducted as an internal quality improvement audit and as such did not require external IRB review.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12886-024-03834-7","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:33:17Z","timestamp":1737552797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy"],"prefix":"10.1186","volume":"25","author":[{"given":"Maximilian","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Eibenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd Uwe","family":"Auffarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanmin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"3834_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.eye.6700194","volume":"16","author":"DG Charteris","year":"2002","unstructured":"Charteris DG, Sethi CS, Lewis GP, Fisher SK. Proliferative vitreoretinopathy\u2014developments in adjunctive treatment and retinal pathology. Eye. 2002;16:369\u201374.","journal-title":"Eye"},{"key":"3834_CR2","unstructured":"Retina. Elsevier; 2006."},{"key":"3834_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","volume":"43","author":"JC Pastor","year":"1998","unstructured":"Pastor JC. Proliferative vitreoretinopathy. Surv Ophthalmol. 1998;43:3\u201318.","journal-title":"Surv Ophthalmol"},{"key":"3834_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/archopht.1962.00960030594005","volume":"68","author":"PA Cibis","year":"1962","unstructured":"Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68:590\u20139.","journal-title":"Arch Ophthalmol"},{"key":"3834_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archopht.1962.00960030394013","volume":"68","author":"MF Armaly","year":"1962","unstructured":"Armaly MF. Ocular tolerance to silicones. I. replacement of aqueous and vitreous by silicone fluids. Arch Ophthalmol. 1962;68:390\u20135.","journal-title":"Arch Ophthalmol"},{"key":"3834_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.11.2.3","volume":"11","author":"M Hammer","year":"2022","unstructured":"Hammer M, Schickhardt S, Munro DJ, Scheuerle A, Mayer CS, Auffarth GU. Physicochemical properties of Explanted Silicone Oil after Use as an intraocular tamponade. Trans Vis Sci Tech. 2022;11:3.","journal-title":"Trans Vis Sci Tech"},{"key":"3834_CR7","doi-asserted-by":"crossref","unstructured":"Hammer M, Schickhardt SK, Munro D, Khoramnia R, Scheuerle A, Mayer CS et al. The novel use of high-flow polyimide cannulas to improve silicone oil injectability in vitreoretinal surgery. Retina. 2022;Publish Ahead of Print.","DOI":"10.1097\/IAE.0000000000003432"},{"key":"3834_CR8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/pharmaceutics14071364","volume":"14","author":"M Hammer","year":"2022","unstructured":"Hammer M, Schickhardt SK, Merz PR, Khoramnia R, Scheuerle AF, Mier W, et al. Intravitreal Application: Physicochemical properties of drugs dissolved in silicone oils of different density in comparison to the porcine vitreous body. Pharmaceutics. 2022;14:1364.","journal-title":"Pharmaceutics"},{"key":"3834_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/bjo.2010.192344","volume":"95","author":"RL Williams","year":"2011","unstructured":"Williams RL, Day MJ, Garvey MJ, Morphis G, Irigoyen C, Wong D, et al. Injectability of silicone oil-based tamponade agents. Br J Ophthalmol. 2011;95:273\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3834_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/IAE.0b013e3181babe0c","volume":"30","author":"RL Williams","year":"2010","unstructured":"Williams RL, Day M, Garvey MJ, English R, Wong D. Increasing the extensional viscosity of silicone oil reduces the tendency for emulsification. Retina. 2010;30:300\u20134.","journal-title":"Retina"},{"key":"3834_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ophtha.2023.12.016","volume":"131","author":"N Tzoumas","year":"2024","unstructured":"Tzoumas N, Yorston D, Laidlaw DAH, Williamson TH, Steel DH, Ellabban AA, et al. Improved outcomes with heavy silicone oil in Complex Primary Retinal detachment. Ophthalmology. 2024;131:731\u201340.","journal-title":"Ophthalmology"},{"key":"3834_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/sj.eye.6703055","volume":"23","author":"D Wong","year":"2009","unstructured":"Wong D, Kumar I, Quah SA, Ali H, Valdeperas X, Romano MR. Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case\u2013control study. Eye. 2009;23:190\u20134.","journal-title":"Eye"},{"key":"3834_CR13","doi-asserted-by":"crossref","unstructured":"Romano, Angi, Romano, Parmeggiani, Campa, Valldeperas, et al. Intraocular pressure changes following the use of silicone oil or Densiron\u00ae 68 as endotamponade in pars plana vitrectomy. OPTH. 2010;:1391.","DOI":"10.2147\/OPTH.S14252"},{"key":"3834_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/eye.2015.3","volume":"29","author":"AC Day","year":"2015","unstructured":"Day AC, Donachie PHJ, Sparrow JM, Johnston RL, Royal College of Ophthalmologists\u2019 National Ophthalmology Database. The Royal College of Ophthalmologists\u2019 National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29:552\u201360.","journal-title":"Eye (Lond)"},{"key":"3834_CR15","doi-asserted-by":"crossref","unstructured":"Moussa G, Bassilious K, Mathews N. A novel Excel sheet conversion tool from Snellen fraction to LogMAR including \u2018counting fingers\u2019, \u2018hand movement\u2019, \u2018light perception\u2019 and \u2018no light perception\u2019 and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021;99.","DOI":"10.1111\/aos.14659"},{"key":"3834_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9394(14)76695-4","volume":"112","author":"R Machemer","year":"1991","unstructured":"Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159\u201365.","journal-title":"Am J Ophthalmol"},{"key":"3834_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40942-022-00413-0","volume":"8","author":"G Moussa","year":"2022","unstructured":"Moussa G, Tadros M, Ch\u2019ng SW, Sharma A, Lett KS, Mitra A, et al. Outcomes of heavy silicone oil (Densiron) compared to Silicone Oil in primary rhegmatogenous retinal detachment: a multivariable regression model. Int J Retin Vitr. 2022;8:61.","journal-title":"Int J Retin Vitr"},{"key":"3834_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00417-006-0496-y","volume":"245","author":"D Sandner","year":"2007","unstructured":"Sandner D, Herbrig E, Engelmann K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol. 2007;245:1097\u2013105.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3129\/i10-107","volume":"46","author":"S Ozdek","year":"2011","unstructured":"Ozdek S, Yuksel N, Gurelik G, Hasanreisoglu B. High-density silicone oil as an intraocular tamponade in complex retinal detachments. Can J Ophthalmol. 2011;46:51\u20135.","journal-title":"Can J Ophthalmol"},{"key":"3834_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000313817","volume":"224","author":"W Li","year":"2010","unstructured":"Li W, Zheng Q, Wang X, Xu M, Wu R. Clinical results of Densiron 68 intraocular tamponade for complicated retinal detachment. Ophthalmologica. 2010;224:354\u201360.","journal-title":"Ophthalmologica"},{"key":"3834_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/eye.2009.57","volume":"24","author":"W Li","year":"2010","unstructured":"Li W, Zheng J, Zheng Q, Wu R, Wang X, Xu M. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye. 2010;24:21\u20138.","journal-title":"Eye"},{"key":"3834_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00347-008-1798-8","volume":"106","author":"T Stappler","year":"2009","unstructured":"Stappler T, Heimann H, Gibran SK, Groenewald C, Pearce IA, Wong D. [Densiron-68 heavy silicone oil in cases of PVR. Anatomic and functional outcomes]. Ophthalmologe. 2009;106:320\u20136.","journal-title":"Ophthalmologe"},{"key":"3834_CR23","doi-asserted-by":"publisher","first-page":"706809","DOI":"10.1155\/2014\/706809","volume":"2014","author":"H Schwarzer","year":"2014","unstructured":"Schwarzer H, Mazinani B, Plange N, Fuest M, Walter P, Roessler G. Clinical observations and occurrence of complications following heavy silicone oil surgery. Biomed Res Int. 2014;2014:706809.","journal-title":"Biomed Res Int"},{"key":"3834_CR24","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1111\/j.1755-3768.2011.02139.x","volume":"89","author":"AM Joussen","year":"2011","unstructured":"Joussen AM, Rizzo S, Kirchhof B, Schrage N, Li X, Lente C, et al. Heavy silicone oil versus standard silicone oil in as vitreous tamponade in inferior PVR (HSO Study): interim analysis. Acta Ophthalmol. 2011;89:e483\u20139.","journal-title":"Acta Ophthalmol"},{"key":"3834_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00417-008-0876-6","volume":"246","author":"S Auriol","year":"2008","unstructured":"Auriol S, Pagot-Mathis V, Mahieu L, Lemoine C, Mathis A. Efficacy and safety of heavy silicone oil Densiron 68\u00ae in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1383\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/archopht.1963.00960050502012","volume":"70","author":"B Becker","year":"1963","unstructured":"Becker B, Mills DW. CORTICOSTEROIDS AND INTRAOCULAR PRESSURE. Arch Ophthalmol. 1963;70:500\u20137.","journal-title":"Arch Ophthalmol"},{"key":"3834_CR27","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1111\/aos.13830","volume":"97","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Russo A, Morescalchi F, Gambicorti E, Vezzoli S, Parmeggiani F, et al. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study. Acta Ophthalmol. 2019;97:e97\u2013102.","journal-title":"Acta Ophthalmol"},{"key":"3834_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00417-004-1039-z","volume":"243","author":"N Kociok","year":"2005","unstructured":"Kociok N, Gavranic C, Kirchhof B, Joussen AM. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane. Graefes Arch Clin Exp Ophthalmol. 2005;243:345\u201358.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1167\/iovs.06-0941","volume":"48","author":"J Mackiewicz","year":"2007","unstructured":"Mackiewicz J, M\u00fchling B, Hiebl W, Meinert H, Maaijwee K, Kociok N, et al. In vivo retinal tolerance of various heavy silicone oils. Invest Ophthalmol Vis Sci. 2007;48:1873\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3834_CR30","doi-asserted-by":"publisher","first-page":"574825","DOI":"10.1155\/2014\/574825","volume":"2014","author":"F Morescalchi","year":"2014","unstructured":"Morescalchi F, Costagliola C, Duse S, Gambicorti E, Parolini B, Arcidiacono B, et al. Heavy silicone oil and intraocular inflammation. Biomed Res Int. 2014;2014:574825.","journal-title":"Biomed Res Int"},{"key":"3834_CR31","first-page":"64","volume":"7","author":"T Banaee","year":"2012","unstructured":"Banaee T. Early decomposition of retained heavy silicone oil droplets. J Ophthalmic Vis Res. 2012;7:64\u20136.","journal-title":"J Ophthalmic Vis Res"},{"key":"3834_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00417-005-0110-8","volume":"244","author":"D Sandner","year":"2006","unstructured":"Sandner D, Engelmann K. First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefe\u2019s Arch Clin Exp Ophthalmo. 2006;244:609\u201319.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmo"},{"key":"3834_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/IAE.0000000000000711","volume":"36","author":"LM Scheerlinck","year":"2016","unstructured":"Scheerlinck LM, Schellekens PA, Liem AT, Steijns D, van Leeuwen R, incidence, risk, factors, and clinical characteristics of unexplained visual loss after intraocular silicone oil for macula-on retinal detachment. Retina. 2016;36:342\u201350.","journal-title":"Retina"},{"key":"3834_CR34","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/00006982-200509000-00032","volume":"25","author":"EN Herbert","year":"2005","unstructured":"Herbert EN, Laidlaw DAH, Williamson TH, Habib M, Steel D, Correspondence. Retina. 2005;25:808\u20139.","journal-title":"Retina"},{"key":"3834_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00417-012-2033-5","volume":"251","author":"M Dogramaci","year":"2013","unstructured":"Dogramaci M, Williams K, Lee E, Williamson TH. Foveal light exposure is increased at the time of removal of silicone oil with the potential for phototoxicity. Graefes Arch Clin Exp Ophthalmol. 2013;251:35\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00006982-200412000-00005","volume":"24","author":"RSB Newsom","year":"2004","unstructured":"Newsom RSB, Johnston R, Sullivan PM, Aylward GB, Holder GE, Gregor ZJ. SUDDEN VISUAL LOSS AFTER REMOVAL OF SILICONE OIL. Retina. 2004;24:871\u20137.","journal-title":"Retina"},{"key":"3834_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40942-017-0079-6","volume":"3","author":"JA Roca","year":"2017","unstructured":"Roca JA, Wu L, Berrocal M, Rodriguez F, Alezzandrini A, Alvira G, et al. Un-explained visual loss following silicone oil removal: results of the Pan American collaborative retina study (PACORES) Group. Int J Retin Vitr. 2017;3:26.","journal-title":"Int J Retin Vitr"},{"key":"3834_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jfo.2009.01.003","volume":"32","author":"G Michel","year":"2009","unstructured":"Michel G, Meyer L, Naoun O. [Sudden visual loss following silicone oil removal: three patients treated for giant retinal tear]. J Fr Ophtalmol. 2009;32:104\u201311.","journal-title":"J Fr Ophtalmol"},{"key":"3834_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1006\/mcne.2001.0962","volume":"17","author":"E Gerhardt","year":"2001","unstructured":"Gerhardt E, K\u00fcgler S, Leist M, Beier C, Berliocchi L, Volbracht C, et al. Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis. Mol Cell Neurosci. 2001;17:717\u201331.","journal-title":"Mol Cell Neurosci"},{"key":"3834_CR40","first-page":"256","volume":"41","author":"M Winter","year":"2000","unstructured":"Winter M, Eberhardt W, Scholz C, Reichenbach A. Failure of potassium siphoning by M\u00fcller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci. 2000;41:256\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3834_CR41","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/bjo.2005.082610","volume":"89","author":"EN Herbert","year":"2005","unstructured":"Herbert EN, Liew SHM, Williamson TH. Visual loss after silicone oil removal. Br J Ophthalmol. 2005;89:1667\u20138.","journal-title":"Br J Ophthalmol"},{"key":"3834_CR42","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/bjo.2003.040402","volume":"88","author":"RHY Asaria","year":"2004","unstructured":"Asaria RHY, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, et al. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol. 2004;88:1439\u201342.","journal-title":"Br J Ophthalmol"},{"key":"3834_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF02144130","volume":"224","author":"B Kirchhof","year":"1986","unstructured":"Kirchhof B, Tavakolian U, Paulmann H, Heimann K. Histopathological findings in eyes after silicone oil injection. Graefes Arch Clin Exp Ophthalmol. 1986;224:34\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR44","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41433-019-0504-1","volume":"33","author":"JYX Lee","year":"2019","unstructured":"Lee JYX, Sawant R, Jonas A, Lochhead J. The incidence of silicone oil-related visual loss following the removal of heavy silicone oil. Eye. 2019;33:1969\u201370.","journal-title":"Eye"},{"key":"3834_CR45","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00417-012-2205-3","volume":"251","author":"KF de Nie","year":"2013","unstructured":"de Nie KF, Crama N, Tilanus MAD, Klevering BJ, Boon CJF. Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction. Graefes Arch Clin Exp Ophthalmol. 2013;251:1373\u201382.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3834_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/sj.eye.6702784","volume":"22","author":"MA Majid","year":"2008","unstructured":"Majid MA, Hussin HM, Biswas S, Haynes RJ, Mayer EJ, Dick AD. Emulsification of Densiron-68 used in inferior retinal detachment surgery. Eye. 2008;22:152\u20137.","journal-title":"Eye"},{"key":"3834_CR47","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/02713683.2020.1795885","volume":"46","author":"A Hostovsky","year":"2021","unstructured":"Hostovsky A, Mandelcorn MS, Mandelcorn ED. Transient Macular Thinning during the Use of Heavy Silicone Oil, Densiron 68. Curr Eye Res. 2021;46:350\u20134.","journal-title":"Curr Eye Res"},{"key":"3834_CR48","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/eye.2009.148","volume":"24","author":"MR Romano","year":"2010","unstructured":"Romano MR, Baddon C, Heimann H, Wong D, Hiscott P. Histopathological findings in an epimacular membrane after intraoperative use of perfluorocarbon liquid. Eye (Lond). 2010;24:740\u20132.","journal-title":"Eye (Lond)"},{"key":"3834_CR49","first-page":"647","volume":"31","author":"K Nakamura","year":"1990","unstructured":"Nakamura K, Refojo MF, Crabtree DV. Factors contributing to the emulsification of intraocular silicone and fluorosilicone oils. Invest Ophthalmol Vis Sci. 1990;31:647\u201356.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3834_CR50","first-page":"1","volume":"2013","author":"V Romano","year":"2013","unstructured":"Romano V, Angi M, Scotti F, del Grosso R, Romano D, Semeraro F, et al. Inflammation and Macular Oedema after Pars Plana Vitrectomy. Mediat Inflamm. 2013;2013:1\u20138.","journal-title":"Mediat Inflamm"},{"key":"3834_CR51","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1167\/iovs.12-10464","volume":"53","author":"M Kim","year":"2012","unstructured":"Kim M, Kim SS, Kwon HJ, Koh HJ, Lee SC. Association between Choroidal Thickness and Ocular Perfusion pressure in Young, healthy subjects: enhanced depth imaging Optical Coherence Tomography Study. Invest Ophthalmol Vis Sci. 2012;53:7710.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3834_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40942-021-00348-y","volume":"7","author":"H Ghanbari","year":"2021","unstructured":"Ghanbari H, Kianersi F, Jamshidi Madad A, Dehghani A, Rahimi A, Feizi A, et al. The effect of silicone oil tamponade on retinal layers and choroidal thickness in patients with rhegmatogenous retinal detachment: a systematic review and meta-analysis. Int J Retin Vitr. 2021;7:76.","journal-title":"Int J Retin Vitr"},{"key":"3834_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000485851","volume":"239","author":"S Karimi","year":"2018","unstructured":"Karimi S, Entezari M, Nikkhah H, Esfandiari H, Darvishpoor T, Tavakoli M, et al. Effects of Intravitreal Silicone Oil on Subfoveal Choroidal Thickness. Ophthalmologica. 2018;239:159\u201366.","journal-title":"Ophthalmologica"},{"key":"3834_CR54","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1097\/IAE.0000000000001437","volume":"37","author":"D Odrobina","year":"2017","unstructured":"Odrobina D, Go\u0142\u0119biewska J, Maroszy\u0144ska I, Choroidal Thickness Chnages After, Vitrectomy with Silicone Oil Tamponde for Proliferative vitreoretinopathy Retinal Detachment. Retina. 2017;37:2124\u20139.","journal-title":"Retina"},{"key":"3834_CR55","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10792-018-0993-0","volume":"39","author":"E Mirza","year":"2019","unstructured":"Mirza E, \u015eat\u0131rtav G, Oltulu R, Kerimo\u011flu H, G\u00fcnd\u00fcz MK. Subfoveal choroidal thickness change following pars plana vitrectomy with silicone oil endotamponade for rhegmatogenous retinal detachment. Int Ophthalmol. 2019;39:1717\u201322.","journal-title":"Int Ophthalmol"},{"key":"3834_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1055\/s-2007-963150","volume":"224","author":"A Lappas","year":"2007","unstructured":"Lappas A, Kirchhof B, Konen W. Linsenver\u00e4nderungen Nach Langzeittamponade Mit Schwerem \u00d6l (Densiron\u00ae). Klin Monatsbl Augenheilkd. 2007;224:434\u20137.","journal-title":"Klin Monatsbl Augenheilkd"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03834-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:03:34Z","timestamp":1737554614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03834-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3834"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03834-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Analyses were approved by the Oxford University Hospitals Integrated Governance System (Oxford University Hospitals Quality Improvement Project approval no. 9440) and were conducted as an internal quality improvement audit. Informed consent was waived by the ethics committee and thus no informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}